U.S. Life Sciences Stock News

Itron (NasdaqGS:ITRI) announced expanded smart water partnerships with Hunter Water in Australia and the Office d'Equipement Hydraulique de Corse in France. The projects involve broad deployments of advanced water metering and cloud-based management platforms across the two utilities. These initiatives target water conservation, operational efficiency, and reduced non revenue water loss in key international markets. Itron focuses on grid edge solutions for utilities, including smart...

Everpure (P) opened 2027 with Q1 revenue of US$1.1 billion and basic EPS of US$0.07, alongside trailing twelve month revenue of US$3.9 billion and EPS of US$0.69 that frame the latest quarter in a broader context. Over the past year, the company has seen revenue move from US$3.3 billion to US$3.9 billion and EPS build from US$0.39 to US$0.69, setting the scene for investors to focus on how margins are holding up through this reporting stretch. See our full analysis for Everpure. With the...

Builders FirstSource Board member Mark A. Alexander resigned from the Board of Directors, effective June 3, 2026. The company stated the decision was due to health reasons and not related to any disagreement over strategy or operations. The change affects the corporate governance structure at Builders FirstSource, which may be relevant for current and prospective shareholders. For investors watching Builders FirstSource (NYSE:BLDR), this Board change comes as the stock trades at $73.64. The...

In early June 2026, Motorola Solutions introduced SafetyCam, a wearable AI assistant that combines video security, two-way communications, a panic button and conversational Assist AI to support retail and other front-line teams with real-time incident visibility and response. By moving beyond passive recording to proactive threat detection, live remote intervention and multilingual voice assistance, SafetyCam deepens Motorola Solutions’ push into integrated, software-rich safety ecosystems...

In late May 2026, AirJoule Technologies Corporation filed a US$14.99 million registered direct follow-on equity offering, issuing 3,658,536 Class A common shares at US$4.10 each, reflecting a US$0.1845 per share discount. This capital raise highlights AirJoule’s continued reliance on equity funding, with the registered direct format likely to influence investor focus on dilution and liquidity. Next, we’ll consider how this registered direct follow-on equity raise, and its implications for...

Event overview: cash generation holds up as volumes soften NewMarket (NEU) reported Q1 conditions in which revenue fell 5% and volumes declined 7%, yet the company still produced solid free cash flow, supporting a yield around 7% as well as ongoing dividends and buybacks. See our latest analysis for NewMarket. The Q1 update comes after a strong run in the stock, with the share price up 14.7% over the past month and 23.2% over the past quarter, while total shareholder return sits at 24.6% over...

Bausch + Lomb has launched Blink Triple Care Preservative Free eye drops in the U.S., offering instant, long-lasting dry eye relief in a preservative-free, multi-dose format now rolling out across major national retailers. This launch extends the Blink franchise into a preservative-free, lipid-based formulation that targets both moisture retention and tear evaporation, reinforcing the company’s focus on differentiated consumer eye care solutions. Next, we’ll examine how this...

Quantum (QMCO) is drawing attention after a cluster of capital structure moves, including terminating a term loan, canceling secured convertible notes, and moving to end a standby equity purchase agreement, alongside updated fourth quarter revenue guidance. See our latest analysis for Quantum. Quantum's recent debt repayments and positive fourth quarter revenue guidance help explain why the stock has a 90 day share price return of 147.56% and a 1 year total shareholder return of 19.47%, even...

AtriCure recently reported strong Q1 2026 earnings and confirmed that its BoxX-NoAF atrial fibrillation trial is running 12 months ahead of schedule, with patient enrollment now expected to be completed by the end of 2026. This faster clinical timeline, combined with momentum in its pain management segment, may tighten the feedback loop between trial outcomes, product adoption, and AtriCure’s long-term growth ambitions. Next, we’ll examine how the accelerated BoxX-NoAF enrollment timeline...

NMI Holdings (NMIH) is back in focus after recent financial updates highlighted strong capital accumulation, improved profitability from fixed cost leverage, and a 17.3% return on equity, prompting fresh scrutiny of the stock’s recent moves. See our latest analysis for NMI Holdings. The share price has firmed in the very short term, with a 1-day share price return of 1.30% and 7-day share price return of 1.81%, but is still down 10% year to date. At the same time, the 3-year total shareholder...

Lamar Advertising: Dividend Signals and Digital Growth Come Into Focus Recent commentary around Lamar Advertising (LAMR) has centered on management reaffirming full year AFFO guidance and indicating room for a higher dividend if current business trends hold. See our latest analysis for Lamar Advertising. The recent reaffirmation of full year AFFO guidance and commentary on dividend capacity arrives as the stock trades at US$151.42, with a 30 day share price return of 7.28% and a 1 year total...

If you are wondering whether Roper Technologies at around US$332 per share offers value or just reflects past enthusiasm, the starting point is to separate price moves from underlying worth. The stock is up about 2% over the past week, but remains down around 5.2% over the past month and has fallen about 23.6% year to date and 41.6% over the last 12 months, which can change how investors view both upside potential and risk. Recent coverage has focused on how software and technology companies...

Context for Telephone and Data Systems stock Telephone and Data Systems (TDS) has drawn investor attention after recent trading left the stock down about 14% over the month and about 13% over the past 3 months, in contrast with a positive 1 year total return. See our latest analysis for Telephone and Data Systems. At a share price of US$39.16, TDS has given investors a mixed ride, with shorter term share price returns weaker while the 1 year and multi year total shareholder returns remain...

FBI armor contract puts Cadre Holdings (CDRE) in focus Cadre Holdings (CDRE) is back on investor radar after subsidiary Safariland was selected as the ballistic panel provider for Predictive Ballistics' Overt Armor Kit under a five year, $61 million FBI contract. See our latest analysis for Cadre Holdings. Despite the FBI contract putting fresh attention on the business, Cadre Holdings’ share price is down 31% over the past 90 days and 27% year to date. However, the 3 year total shareholder...

DocuSign (DOCU) has kicked off Q1 2027 with total revenue of US$830.2 million and basic EPS of US$0.40, setting the stage for investors to reassess how the business is converting its top line into earnings. The company has seen quarterly revenue move from US$763.7 million in Q1 2026 to US$830.2 million in Q1 2027, while basic EPS shifted from US$0.35 to US$0.40 over the same stretch, giving you a clear read on how sales and earnings are tracking into the new fiscal year as margins come under...

A law firm has opened an investigation into Roblox (NYSE:RBLX) over potential fraud, negligence, or other unlawful practices, raising fresh questions about governance and legal risk for the platform. Separately, Roblox is overhauling its discovery algorithm to emphasize deeper user engagement and long term retention instead of immediate monetization. The company is aiming to improve content quality and appeal more to adult users. Roblox runs a global user generated gaming and experiences...

Over the past week, SEALSQ (NasdaqGS:LAES) has announced a majority stake in Wecan Group, the acquisition of Swiss photonics firm Miraex, and a lead investment role in EeroQ and Quobly funding rounds. These moves extend SEALSQ's reach across post quantum security, quantum processors, and AI driven compliance tools in both Europe and the US. The transactions are presented as completing SEALSQ's Quantum Sovereign Vertical Stack and shifting the company toward a broader quantum platform...

Clearway Energy stock performance snapshot Clearway Energy (CWEN) has drawn investor attention after a mixed stretch in its share price, with the stock down 1.6% over the past day but up 3.2% over the past month. See our latest analysis for Clearway Energy. At a share price of $39.74, Clearway Energy has seen short term momentum cool with a 1-week share price return down 3.5%, even as the year to date share price return of 17.0% and 1-year total shareholder return of 37.1% point to stronger...

Recent performance snapshot for Omega Healthcare Investors Omega Healthcare Investors (OHI) has seen mixed share performance recently, with the stock up about 1.8% over the past day but down around 5% over the past week and 3% over the past month. Over longer periods, the stock shows a different pattern, with total return of about 26% over the past year and very large multiyear gains, including roughly 7x over three years and about 0.8x over five years. See our latest analysis for Omega...

Wondering if KeyCorp's share price still reflects good value after a strong run, or if most of the easy gains are behind it? This article walks through what the current valuation actually says. KeyCorp shares last closed at US$21.76, with the stock up 2.0% over the past week, slightly down 2.1% over the past month, up 3.7% year to date, and up 38.9% over the past year, while the 3 year and 5 year returns stand at 137.8% and 26.4% respectively. Recent price moves sit against a backdrop of...

ADC Therapeutics (ADCT) has drawn fresh attention after reporting statistically significant Phase 3 LOTIS-5 topline data for ZYNLONTA plus rituximab in relapsed or refractory diffuse large B cell lymphoma, including improved progression free survival versus standard therapy. See our latest analysis for ADC Therapeutics. Despite the encouraging LOTIS-5 data, the stock’s 1-day share price return fell 21.97%, extending a 7-day share price decline of 69.71% and a 1-year total shareholder return...

If you are wondering whether Synopsys at around US$464.85 is priced for opportunity or already reflects high expectations, the key is to understand what different valuation tools actually say about the stock. Over shorter periods the picture has been mixed, with the share price down about 2.3% over the last week, down 7.8% over the last month, down 3.2% year to date, and down 4.4% over the last year. The 3 year and 5 year returns sit at 5.9% and 76.7% respectively. Recent coverage of...

Keel Infrastructure (NasdaqGM:KEEL) has completed an upsized US$400 million convertible senior notes offering, above the initial US$350 million target. The transaction is intended to fund capped call arrangements and support expansion of data center projects for AI and high performance computing workloads. The offering adds financial flexibility as Keel continues its shift from Bitcoin mining toward broader digital infrastructure. Keel is positioning itself as a digital infrastructure...

For investors wondering whether Brookfield Infrastructure at around US$41.31 offers value or is asking too much for its future, this breakdown is designed to help frame that question in a clear, practical way. The stock has been slightly softer over the last week, with a 0.5% decline, but has gained 4.6% over the past month. Year to date it is down 8.8% and it is up 5.7% over the last year, with a 2.1% decline over three years and a 7.3% gain over five years. Recent price moves sit against a...